The FDA has granted EUA to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus. Read more...
Stero Biotechs, in a collaboration with its main partner and shareholder, Mor Research Applications announced a new clinical trial in the global efforts of fighting the COVID-19 virus. Read more...
PDI Healthcare is testing several of its disinfectant products for efficacy against SARS-CoV-2, the virus that causes COVID-19, for submission to the EPA for approval. Read more...
Novartis has reached an agreement with the FDA to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19. Read more...